The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats
Abstract
Rationale Elevations in cAMP response element binding protein (CREB) function within the mesolimbic system of rats reduce cocaine reward in place conditioning studies and increase immobility in the forced swim test. Each of these behavioral adaptations can be interpreted as a depressive-like effect (i.e., anhedonia, despair) that may reflect reduced activity of brain reward systems. Furthermore, each effect appears due to increases in CREB-mediated expression of dynorphin, since each is attenuated by intracranial injections of the kappa-opioid receptor antagonist norBNI.Objectives Intracranial self-stimulation (ICSS) studies were conducted in rats to determine whether administration of a kappa-agonist would have depressive-like effects on brain stimulation reward, and whether pretreatment with a kappa-antagonist would attenuate any such effects. Conditions that have depressive effects in people (e.g., drug withdrawal) increase the threshold amounts of stimulation required to sustain ICSS in rats.Methods Sprague-Dawley rats with lateral hypothalamic stimulating electrodes were tested in a "curve-shift" variant of the ICSS procedure after systemic administration of the kappa-agonist U-69593 alone, the novel kappa-antagonist 5'-acetamidinoethylnaltrindole (ANTI) alone, or co-administration of both drugs.Results U-69593 dose dependently increased ICSS thresholds, suggesting that activation of kappa-receptors reduced the rewarding impact of the brain stimulation. ANTI had no effects on its own, but it attenuated increases in ICSS thresholds caused by the agonist.Conclusions These data provide further evidence that stimulation of brain kappa-receptors may trigger certain depressive-like signs, and that kappa antagonists may have efficacy as antidepressants without having reward-related actions of their own.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Much evidence shows that the activation of k-opioid receptor agonists elevates intracranial self-stimulation reward thresholds and decreases the function of the mesolimbic dopamine system (Todtenkopf et al., 2004;Chefer et al., 2013).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Todtenkopf et al., 2004
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733 · cited 2×
“Dynorphin acts at k-receptors on dopaminergic terminals (Svingos et al. 1999) to inhibit DA release in the NAc (Di Chiara and Imperato 1988; Maisonneuve et al. 1994).”
BackgroundDepression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451 · cited 2×
“Elevated CREB activity within the NAc also increases immobility behaviors in the forced swim test (FST), a depressive-like effect (Pliakas et al. 2001) that may reflect “behavioral despair” (Porsolt et al. 1977).”
BackgroundBardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
The rat brain in stereotaxic coordinates (2nd edn)
Herman, J. P., & Watson, S. J. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90017-8 · Cited by 1,753
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168 · cited 2×
“These behavioral effects appear related to the ability of CREB to regulate transcription of dynorphin (Cole et al. 1995; Carlezon et al. 1998), an endogenous kopioid receptor ligand (Chavkin et al. 1982).”
BackgroundG-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,166 · cited 1×
“ANTI may also act at heterodimers composed of two or more types of opioid receptors (Jordan and Devi 1999; Simonin et al. 2001; Portoghese and Lunzer 2003).”
BackgroundNeuroleptics and operant behavior: The anhedonia hypothesis
Wise, R. A. (1982) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00010372 · Cited by 1,016 · cited 4×
“For example, antipsychotic drugs (Wise 1982) or drug withdrawal (Markou et al.”
BackgroundInfluentialPsychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857 · cited 1×
“Moreover, humans report that k-opioid agonists cause states of dysphoria (Pfeiffer et al. 1986; Roth et al. 2002), another symptom of clinical depression.”
BackgroundSalvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182234399 · Cited by 784 · cited 2×
“Moreover, humans report that k-opioid agonists cause states of dysphoria (Pfeiffer et al. 1986; Roth et al. 2002 ), another symptom of clinical depression.”
BackgroundRegulation of cocaine reward by CREB
Carlezon, W. A., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., Duman, R. S., Neve, R. L., & Nestler, E. J. (1998) · Science · doi:10.1126/science.282.5397.2272 · Cited by 767
Self-citation
Cited by
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
“Administration of agonists produces effects similar to those produced by increased CREB activity in the NAc, including increased immobility in the forced swim test (Mague et al 2003) and signs of anhedonia in reward models (Todtenkopf et al 2004).”
BackgroundSelf-citationCARLEZONJR, W., DUMAN, R., & NESTLER, E. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.06.005 · Cited by 1,346
Self-citationREVIEW: Behavioural assessment of drug reinforcement and addictive features in rodents: an overview
Sanchis‐Segura, C., & Spanagel, R. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00012.x · Cited by 629
Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis
Carlezon, W. A., & Thomas, M. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.075 · Cited by 561
“…to that caused by prodepressive treatments including drug withdrawal (Markou et al., 1994) and k-opioid receptor agonists (Pfeiffer et al., 1986; Wadenberg, 2003; Todtenkopf et al., 2004; Carlezon et al., 2006), suggesting that it reflects decreases in the rewarding impact of the stimulation.”
Self-citationAddiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
“Subsequent activation of dynorphin systems has been hypothesized to feedback to decrease dopamine release in the mesolimbic dopamine system (Todtenkopf et al., 2004; Pliakas et al., 2001; Nestler, 2004; Mague et al., 2003; Knoll and Carlezon, 2010) and glutamate release in the nucleus accumbens (Hjelmstad and Fields,…”
Background
Metadata
- Authors
- Todtenkopf, M. S., Marcus, J. F., Portoghese, P. S., & Carlezon, W. A.
- Affiliations
- Harvard University (US)
- University of Minnesota (US)
- Corresponding author
- Carlezon, William A.
- Venue
- Psychopharmacology
- Published
- 2004-01-16
- Volume
- 172
- Issue
- 4
- Pages
- 463-470
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1980915383
- Cited by
- 273
- References
- 51
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 6 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 9 · 2018: 17 · 2017: 10 · 2016: 11 · 2015: 17 · 2014: 17 · 2013: 22 · 2012: 16
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh063266-25)
- National Institute of Mental Health (MH63266)
- National Institute on Drug Abuse (DA01533)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- kappa opioid receptor, intracranial self-stimulation, reward, depression, antidepressants, U69593, dynorphin, CREB, mesolimbic system, anhedonia, drug withdrawal
- MeSH terms
- Animals, Behavior, Animal, Brain, Dose-Response Relationship, Drug, Drug Interactions, Dynorphins, Electric Stimulation, Electrodes, Implanted, Injections, Intraperitoneal, Ligands, Male, Naltrexone, Pyrrolidines, Reward, Self Stimulation, Time Factors, Rats, Sprague-Dawley, Receptors, Opioid, kappa, Benzeneacetamides, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats. https://app.cochat.ai/papers/10.1007/s00213-003-1680-y
- The paper
- Todtenkopf, M. S., Marcus, J. F., Portoghese, P. S., & Carlezon, W. A. (2004). Effects of κ-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology. https://doi.org/10.1007/s00213-003-1680-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.